PATENT CLAIM ANALYSIS

Application Number: 16289526
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "085200"]

Abstract:
Provided herein are pharmaceutical compositions comprising tumoricidal and/or antimicrobial components isolated from the supernatant of NK-92 cell medium and methods of using the compositions for killing cancer cells.

Claim (Index 46):
The method of  claim 37 , wherein the pharmaceutical composition is a cream or lotion.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 99.0
- Lexical Diversity: 1.11538
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16212578', '16289494', '15032518', '12833694', '14649054']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7566097453062673
- 35 USC 102 Novelty (BERT): 0.5463315127967504
- Combined Prediction Score: 0.7355819220553157
- Mean Citation Score: 314.42934
- Max Citation Score: 400.44717
- Similarity Product: 301.27102314371115

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test